Critics of impending changes to medical spending accounts have been arguing for months to push back provisions that will take effect by the beginning of next year. Last week, the IRS issued guidance on such changes that aims to clarify certain restrictions on medical expense reimbursement through these accounts.
According to IRS guidelines, beginning Jan. 1, employees won't be able to make over-the-counter drug purchases using their flexible spending account or health reimbursement account unless they have a prescription.
Guidelines state the cost of an OTC drug or medicine can't be reimbursed unless the item is a prescribed drug, or if the medication is available over the counter and the purchaser obtains a prescription. Insulin will also be reimbursed even if there isn't a prescription.
Recommended For You
The change also doesn't affect other health care expenses such as medical devices, eye glasses, contact lenses, co-pays and deductibles.
Non-drug or non-medicine items like crutches, bandages and blood sugar tests will still qualify for reimbursement by a health FSA or HRA regardless if they are purchased using a prescription.
However, the OTC change won't take effect until after Dec. 31, which means account holders have until then to stock up on drugs like Aspirin, which doesn't require a prescription for reimbursement. Claims for 2010 expenses can also be reimbursed in 2011.
But for any expenses incurred on and after Jan. 1, account holders will need to obtain the required prescription, which the IRS has defined as "written or electronic order for a medicine or drug that meets the legal requirements of a prescription in the state in which a medical expense is incurred and that is issued by an individual who is legally authorized to issue a prescription in that state."
Those with health savings accounts will also see an increased penalty for expenses that don't qualify for reimbursement. According to the IRS, withdrawals for OTC, non-prescribed drugs or non-medical-related items will be penalized by 20 percent instead of the current 10 percent.
Effective dates and grace period
According to the IRS, reimbursements for expenses incurred after Dec. 31, 2010 are restricted to prescribed drugs, insulin and OTC drugs that are prescribed. The effective date applies regardless of whether the plan year for the employer's plan is a fiscal or calendar year or whether there is no plan year.
As for HSAs or Archer MSAs, tax-free distributions for qualified medical expenses from these accounts are restricted to prescribed drugs, OTC medicines that are prescribed, or insulin.
At a company's discretion, health FSAs can include a grace period that extends a few months into the following year after a plan year has ended. According to guidelines, if a health FSA includes a grace period provision, costs for OTC medicines and drugs purchased without a prescription during the first 2 1/2 months of 2011 will not be eligible for reimbursement.
Debit cards
Debit card systems currently can't recognize and substantiate whether medicines or drugs were prescribed. So they'll be useless next year to purchase OTC drugs or medicines. Participants will need to purchase the medicine, then provide a receipt and prescription (or copy of prescription), or receipt and Rx number.
However, the IRS is going to allow time for the plan to ensure that the card is reprogrammed, so it will allow card usage until Jan. 15, 2011.
Groups challenge FSA provision date
The IRS released official guidance regarding the use of FSAs and other tax-favored arrangements on Sept. 3, and the fast-approaching effective date has industry groups and benefit administrators scrambling to prepare.
Grassroots advocate Save Flexible Spending Plans has pushed for a 2014 implementation date to coincide with the start date of many other provisions under the Patient Protection and Affordable Health Care Act.
"This common-sense approach would provide a much better transition period for participants, including those battling chronic conditions, to be educated about the new rules and have a reasonable amount of time to find new ways to finance their health care costs," the group said in a statement released in March.
"This restriction will hurt millions of consumers who rely on their FSAs to manage their out of pocket health care costs and pay for necessary over-the-counter therapies," notes Joe Jackson, CEO of WageWorks Inc., a benefits company based in San Mateo, Calif. "If Congress is intent on putting this provision into effect, they should at least push back the deadline so that consumers and especially retailers are ready for the transition."
Q & A on OTC medications and drugs:
|
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.